01 4NEUROCRINE
01 411730739
01 4Blank
01 4Blank
01 42035-01-21
Patent Expiration Date : 2035-01-21
US Patent Number : 11730739
Drug Substance Claim :
Drug Product Claim :
Application Number : 218808
Patent Use Code : U-4049
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-01-21
Patent Expiration Date : 2035-01-21
US Patent Number : 11730739
Drug Substance Claim :
Drug Product Claim :
Application Number : 218808
Patent Use Code : U-4049
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-01-21
Patent Expiration Date : 2035-01-21
US Patent Number : 11730739
Drug Substance Claim :
Drug Product Claim :
Application Number : 218808
Patent Use Code : U-4049
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-01-21
Patent Expiration Date : 2035-01-21
US Patent Number : 11730739
Drug Substance Claim :
Drug Product Claim :
Application Number : 218820
Patent Use Code : U-4049
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-01-21
